I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Laparoscopic myomectomy is a safe and feasible option for women with symptomatic myomas who desire uterine conservation. This minimally invasive procedure is associated with better postoperative outcomes, including less postoperative pain, quicker recovery, and fewer overall complications, compared with abdominal myomectomy. There are many reports of parasitic myomas after laparoscopic uncontained morcellation of uterine fibroids.\[[@ref1][@ref2][@ref3]\] The overall incidence of parasitic myomas after laparoscopic surgery with the use of uncontained morcellation is reported to be 0.9%.\[[@ref4]\] We report a case of multiple parasitic myomas after uncontained electromechanical morcellation.

C[ASE]{.smallcaps} R[EPORT]{.smallcaps} {#sec1-2}
=======================================

A 24-year-old unmarried woman presented with lower abdominal pain of 6 months' duration. She had undergone laparoscopic myomectomy for a 15-cm posterior intramural degenerated myoma 2 years back. The specimen was removed via uncontained morcellation with electromechanical tissue morcellator and the specimen weighed 900 g. She had recurrence of myoma after 2 years and treated with ulipristal acetate for 3 months.

On clinical examination, the uterus enlarged to 20 weeks' gravid uterus size. Transabdominal ultrasound showed enlarged uterus with multiple myomas including largest fundoposterior wall myoma of 9 cm and posterior wall myoma of 6 cm. Laparoscopy revealed an enlarged uterus with multilobulated degenerated myoma of 15 cm in the fundoposterior region and other 5 myomas of 3--4 cm in the posterior wall. There were multiple parasitic myomas of 1--3 cm in the pelvis and anterior abdominal wall \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. All the myomas were removed from the uterus and the myometrium was sutured with barbed sutures. Eleven parasitic myomas of 1--3 cm were excised from pelvic wall, uterovesical fold, and anterior abdominal wall. For reducing the risk of recurrence of parasitic myomas, all the myomas were placed in a specially designed endobag (MorSafe tissue isolation bag (Veol Technologies, Mumbai, Maharashtra, India)) and removed from the peritoneal cavity by in-bag morcellation as described earlier.\[[@ref5]\] Histopathology of all the myomas including parasitic myomas confirmed the diagnosis of leiomyoma.
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D[ISCUSSION]{.smallcaps} {#sec1-3}
========================

The first case of a parasitic myoma after use of the laparoscopic morcellation was reported in 1997 by Ostrzenski.\[[@ref6]\] There were many reports of iatrogenic parasitic myomas afterward.\[[@ref1][@ref2][@ref3]\] During electromechanical morcellation, small tissue fragments are easily lost in the peritoneal cavity and can regrow into parasitic myomas.\[[@ref7]\] Gonadal steroid hormones are known to influence the growth of uterine fibroids.\[[@ref8]\] Likewise, it is hypothesized that prolonged exposure to steroid hormones such as hormonal replacement therapy could be a risk factor for the development of parasitic myomas.\[[@ref9]\] Takeda *et al*.\[[@ref1]\] compared the histological appearance of multiple parasitic myomas found 6 years after laparoscopic myomectomy with electric tissue morcellation, with the histological results of the myoma removed at the initial surgery. The histopathological findings were almost identical and the presence of progesterone receptors was reported in both the parasitic myomas and the previously removed myoma. The impact of hormones on the development of parasitic myomas was illustrated by a case of rapid growth of a parasitic myoma during pregnancy. Takeda *et al*.\[[@ref1]\] published a case report of a woman who was diagnosed with a parasitic myoma 2 years after a laparoscopic myomectomy. After 2 years of conservative treatment, the size of the mass remained the same; yet during pregnancy, rapid growth of this mass was observed, supporting the hormonal impact on the growth of parasitic myomas.

The clinical presentations of parasitic myomas are nonspecific. Patients may present with pain, pelvic pressure, dyspareunia, abdominal or pelvic mass, or even may be asymptomatic.\[[@ref2][@ref10]\] As these symptoms are more commonly associated with uterine myomas, the diagnosis of parasitic myomas is often incidental at the time of surgery for symptomatic uterine myomas. Clinically, any mass separated from the uterus in case of previous laparoscopic morcellation of myoma should raise the suspicion of parasitic myoma. The identification of myoma-like lesions outside pelvis by ultrasonography may aid in the diagnosis. Magnetic resonance imaging (MRI) is the most reliable technique in such cases. It can accurately demonstrate the location of the tumor relative to adjacent structures such as the ureter, bladder, or rectum.\[[@ref11]\] In the present case, the diagnosis of parasitic myoma was made only during laparoscopy. Takeda *et al*.\[[@ref1]\] had identified multiple tumors ranging from 1 to 6 cm with unknown origin in the lower abdomen on MRI, but the diagnosis of parasitic myomas was possible only at laparoscopy. Clark *et al*.\[[@ref3]\] diagnosed parasitic myoma with the help of MRI.

Management of parasitic myomas is usually excision. In our case, all parasitic myomas were excised without complications. Sometimes, parasitic myomas can be adherent to vital organs and excision can be risky. Takeda *et al*.\[[@ref1]\] had identified multiple parasitic myomas ranging from 1 to 6 cm in the lower abdomen; out of them, one myoma on the left pelvic sidewall was firmly attached to peritoneal tissue adjacent to the ureter. Since there was concern about the risk of ureteral injury, a ureteral stent was placed in the left ureter under cystoscopic observation before blunt dissection, and then the nodule was removed. Clark *et al*.\[[@ref3]\] had found two parasitic myomas. One (17.5 cm × 13 cm) was enwrapped in the sigmoid mesocolon and other (5.2 cm × 3.2 cm) was identified in the hepatorenal fossa, the decision was made to convert to a laparotomy. Both of these masses were carefully separated from the adjacent organs and excised. Excision of myomas was done in other studies also.\[[@ref1][@ref2][@ref3][@ref9]\]

Since parasitic myomas grow from retained fragments of morcellated myomas, every attempt should be made to reduce fragmentation and dissemination during specimen removal. Mini-laparotomy and colpotomy with manual morcellation within a specimen bag are options to reduce the occurrence of parasitic myomas. Contained in-bag morcellation is another alternative to reduce this complication.\[[@ref5]\] If at all uncontained morcellation has to be performed, all residual fragments which may be buried under bowel or bladder or stuck in cannulas and wedged in the abdominal wall should be removed completely.\[[@ref10]\] We preferred to remove all the myomas by in-bag morcellation technique.

Laparoscopic myomectomy with uncontained tissue morcellation is a major risk factor for parasitic myomas. In patients with a history of laparoscopic morcellation who report pelvic symptoms, iatrogenic parasitic myomas as a late complication should be considered in the differential diagnosis. Meticulous surgical technique with systematic surveying of the entire cavity and complete retrieval of even small fragments of morcellated tissue should be practiced so as not to iatrogenically increase the risk of morbidity associated with parasitic myomas.
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